Insmed | Ordinære Aksjekapital



Ordinary Share Capital Endring Dato
BioMarin Pharmaceutical USD 191K 0 2024-12
Cytokinetics USD 118K 0 2024-12
DBV Technologies USD 10.98M 1000 2024-09
Dynavax Technologies USD 125K 6K 2024-12
Gilead Sciences USD 1000K 0 2024-12
Insmed USD 1.79M 6K 2024-12
Novartis USD 793M 0 2024-12
Regeneron Pharmaceuticals USD 100K 2K 2024-09
Sarepta Therapeutics USD 10K 0 2024-12
Ultragenyx Pharmaceutical USD 92K 0 2024-12
Vertex Pharmaceuticals USD 2.6M 0 2024-12



Insmed Ordinære Aksjekapital - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Apr 2025.